DE3888012T2 - Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel. - Google Patents

Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel.

Info

Publication number
DE3888012T2
DE3888012T2 DE3888012T DE3888012T DE3888012T2 DE 3888012 T2 DE3888012 T2 DE 3888012T2 DE 3888012 T DE3888012 T DE 3888012T DE 3888012 T DE3888012 T DE 3888012T DE 3888012 T2 DE3888012 T2 DE 3888012T2
Authority
DE
Germany
Prior art keywords
benzamides
imidazol
substituted
antiarrhythmic agents
class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3888012T
Other languages
English (en)
Other versions
DE3888012D1 (de
Inventor
Klaus Nickisch
Randall Edward Lis
William Carl Lumma
Thomas Kenneth Morgan
Ronald Andre Wohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of DE3888012D1 publication Critical patent/DE3888012D1/de
Publication of DE3888012T2 publication Critical patent/DE3888012T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE3888012T 1987-05-05 1988-05-02 Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel. Expired - Lifetime DE3888012T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/046,222 US4804662A (en) 1987-05-05 1987-05-05 Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents

Publications (2)

Publication Number Publication Date
DE3888012D1 DE3888012D1 (de) 1994-04-14
DE3888012T2 true DE3888012T2 (de) 1994-10-13

Family

ID=21942261

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3888012T Expired - Lifetime DE3888012T2 (de) 1987-05-05 1988-05-02 Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel.

Country Status (5)

Country Link
US (1) US4804662A (de)
EP (1) EP0290377B1 (de)
AT (1) ATE102191T1 (de)
DE (1) DE3888012T2 (de)
ES (1) ES2051885T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
WO1991018904A1 (en) * 1990-05-30 1991-12-12 American Home Products Corporation Substituted arylsulfonamides and benzamides
US5189036A (en) * 1990-06-20 1993-02-23 Schering Ag Imidazolylbenzoyl substituted heterocycles
HU221317B1 (en) * 1991-08-14 2002-09-28 Procter & Gamble Pharma 2,4-imidazolidinedione derivatives and antiarrhythmic and antifibrillatory compositions containing them, and process for producing them
US5183813A (en) * 1992-02-19 1993-02-02 Sterling Winthrop Inc. Antiarrhythmic agents
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
US5795893A (en) * 1994-12-22 1998-08-18 Smithkline Beecham Corporation Fibrinogen receptor antagonists
SK18097A3 (en) * 1996-02-28 1997-10-08 American Cyanamid Co Substituted omega £phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl| £alkyl, alkenyl or alkinyl|amino carboxamides, sulfonamides and phosphonyl amides, pharmaceutical preparation containing them, process for producing them and their use
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
WO2008057543A2 (en) * 2006-11-06 2008-05-15 Acadia Pharmaceuticals Inc. Uii-modulating compounds and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds

Also Published As

Publication number Publication date
EP0290377B1 (de) 1994-03-02
US4804662A (en) 1989-02-14
EP0290377A1 (de) 1988-11-09
ATE102191T1 (de) 1994-03-15
ES2051885T3 (es) 1994-07-01
DE3888012D1 (de) 1994-04-14

Similar Documents

Publication Publication Date Title
ATE33635T1 (de) Substituierte sulfonamidbenzamide, antiarythmische mittel und deren zusammensetzungen.
DE3888012D1 (de) Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel.
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
MY101791A (en) New benzimidazole derivatives
SE9604786D0 (sv) New compounds
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
SE7903186L (sv) Cerebralverksamt medel
FR2636948A1 (fr) N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant
EP0131302A3 (en) Imidazoliums, intermediates thereto and their use
DE3785046A1 (de)
SE8404065D0 (sv) Novel biologically active compounds
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
BR9007115A (pt) Novo trombolitico
DE3586194T2 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
SE8600658D0 (sv) Novel composition of matter
DK192988D0 (da) Dihydropyridinamider, deres fremstilling og anvendelse
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
NO922136D0 (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
FI861329A (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
DE3764697D1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
DE69113437T2 (de) Therapeutische Mittel für diabetisches Gangrän.
IT8421046A0 (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.
DE3771548D1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
FR2579463B1 (fr) Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8330 Complete renunciation